6 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Development and Application of a New Class of Halogenated Reagents to Commercially Valuable Targets (Halo)
Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,
...of Surgeons in Ireland, “RCSI”](ii) Enantioselective fluorination [Nagoya University Japan, “Nagoya”](iii) Drug development and production [Integrated Research in Biotechnology & Medicine, “IRBM”]To meet the aim we have divided the project into the following work packages:WP1: Development of a new synthesis of Tolterodine.WP2: Scale up of synthesis of Tolterodine. WP3: Development of a new synthes ...
Voir le projet
2
Participants partenaires
TERMINÉ
THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia (THALAMOSS)
Date du début: 1 nov. 2012, Date de fin: 31 oct. 2016,
...niversity, Italy), S. Menzel and SL.Thein (King’s College Hospital, UK), E.Voskaridou (Laiko General Hospital, Greece). Participating SMEs are Biocep (Israel), NovaMechanics Ltd. (Cyprus) and IRBM (Italy). Industrial activities are also provided by Harbour Antibodies (The Netherlands).
Voir le projet
14
Participants partenaires
TERMINÉ
Targeting the HIV-1 Nucleocapsid Protein to fight Antiretroviral Drug Resistance (THINPAD)
Date du début: 1 sept. 2013, Date de fin: 31 août 2016,
AIDS is one of the most serious pandemic diseases of the modern era. Although current therapies based on targeting key processes of the HIV replication cycle are potent and selective, several clinical failures are recorded due to the emergence of drug resistance. Hence, there is an urgent need for novel drugs and alternative therapeutic strategies.The objective of the THINPAD proposal is to discov ...
Voir le projet
5
Participants partenaires
TERMINÉ
"A new methodology based on an advanced molecular probe for early detection of DPD enzyme deficiency in oncological patients, also enabling a personalised and effective drug management" (CARESS)
Date du début: 1 mai 2013, Date de fin: 30 juin 2015,
"Amongst all the chemotherapy agents, 5-FU (fluorouracil) is being in use since 40 years, and is one of the most successful and widely employed in the treatment for breast, colon, and skin cancer, three of the most frequently occurring malignant tumours. In general, 5-FU is relatively well tolerated at standard doses, but there are some important issues that must be duly taken into consideration: ...
Voir le projet
7
Participants partenaires
TERMINÉ
European Infrastructure of Open Screening Platforms for Chemical Biology (EU-OPENSCREEN)
Date du début: 1 nov. 2010, Date de fin: 30 avr. 2015,
The EU-OPENSCREEN Preparatory Phase forms the basis for the construction and operation of a pan-European infrastructure of open screening platforms for Chemical Biology. EU-OPENSCREEN will bring together leading laboratories from 14 European countries covering all aspects of Chemical Biology from high-throughput screening with a dedicated compound library to assay development, chemical synthesis f ...
Voir le projet
24
Participants partenaires
TERMINÉ
On-line industrial water quality analysis system for rapid and accurate detection of pathogens (AQUALITY)
Date du début: 1 déc. 2011, Date de fin: 31 mars 2014,
"Currently the identification and quantification of pollutants in water are mostly carried out manually through sampling and subsequent laboratory analysis (off-line analysis), with methodologies of work that involve some significant costs in terms of displacement to sampling points, reagents and specialized personnel dedicated to the operation, leading to time consuming and economically challengi ...
Voir le projet